Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) in Children 9–23 Months of Age in Russian Federation: Results of Russian Part of International Study in Russia and India

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) in Children 9–23 Months of Age in Russian Federation: Results of Russian Part of International Study in Russia and India

Aim. Assessment of tolerability, safety and immunogenicity of the 4-valent conjugated meningococcal MenACYW-D vaccine, administered 2 times to children 1–2 years of age in the Russian Federation.Study participants. 100 children aged 9–17 months not previously vaccinated against meningococcal infecti...

Full description

Bibliographic Details
Main Authors: O. A. Perminova, V. V. Romanenko, V. Yu. Rodnikova, S. M. Kharit, Y. Thollot, V. Bosch-Castells, A. V. Goldstein
Format: Article
Language:Russian
Published: Numikom LLC 2020-05-01
Series:Эпидемиология и вакцинопрофилактика
Subjects:
менингококковая вакцина
безопасность
реактогенность
дети
Online Access:https://www.epidemvac.ru/jour/article/view/984

Similar Items

Similar Items